|
|
Morning Folks! Jeff Bishop here again with another hot stock idea. |
As you start your week off, make sure you check out the Market Masters live trading room. |
This is where you'll find updates on stocks I talk about and also new ideas the community is trading. |
We used to price this at over $100/month… but I'm giving it away to everyone at absolutely no cost right now. |
Take advantage of this great opportunity for more education and trading ideas each week. |
Now, as I discussed in last night's email, the small-cap market has been roaring back to life in no small part due to "Roaring Kitty" and his legion of rabid following of traders on Reddit and X. |
It's a good window of time to look for strong momentum stocks that could keep moving higher (like the recent biotech stock I shared with you that rallied over 30%, or the "Bird Flu" stock that went up over 50% after I shared them both with you.) |
I also think there is a great opportunity when it comes to searching for "bottom bounce" opportunities. |
You know, those stocks that have gotten to a point where they are so oversold, that it is almost a no-brainer they will bounce back at some point. |
That is exactly what I have in store for you today. |
Go to your platform and pull up MIRA Pharmaceuticals (MIRA) right now. |
It's almost too irresistible right now. |
MIRA has been completely ignored by traders for so long, and I think now is the perfect time to get it back on your radar. |
You'll notice that the stock price has slowly drifted all the way down to around $.60 today, but it has traded over 10 times higher than that earlier in the year. |
If you look back to the chart in March, you'll see just how fast this stock can run when it wants to. |
That is when MIRA made a 2-day power surge that carried the shares over 100% higher at one point. |
If you go back a few more months, you'll see the move we all dream about… that is when MIRA shot up over 370% over the course of a few days. |
I doubt we'll see a move like that anytime soon, but one can certainly dream! |
When it comes to the current price levels, this is where it gets really interesting for me. |
Since MIRA tested $.63 a few times, I would personally set a closing price just under that as a stop, or the point I would go to the sidelines. |
It's only around $.05 lower than the current price, so there is not much downside if that is properly managed. |
On the upside though, just look at how much range there is? |
The last resistance point when MIRA bounced last month was $.90, or over 40% higher from here. |
I am not saying the stock will suddenly shoot there, but it gives you a good perspective on the upside vs downside ranges to look for. |
With so many traders out there searching for new opportunities in the small-cap space, I think it makes perfect sense MIRA could be a rebound target. |
Just last week, Zacks issued a report that said MIRA has a "Potential Game-Changing Drug Submission." |
Exposure like that could be just the thing that creates enough spark to get investors fired up about this stock once again. |
Make sure you are closely watching MIRA today! |
Let's discuss more about what MIRA is working on right now. |
As you know, anxiety impacts a lot of people, making it a big market for drug companies. |
And sadly it's growing fast (bad for people) but great for companies. |
How big is it, and how fast is it growing? |
|
But there's hope. |
From marijanua (arguably) to psychedelic mushrooms (Steve Jobs was right again) to new therapeutics - solutions are coming to market at a seemingly record pace. |
This brings me to MIRA, a tiny biotech that is targeting a potential $3 billion market by 2035, with estimates rising to $7.8 billion, according to IQVIA. |
Yet it's trading with a market cap of just under $10 million as of Friday's closing price (reported by Yahoo Finance). |
And with its tiny float, it's no shocker it was able to make that incredible 370% move higher back in November last year. |
I think catalysts are coming that could help this low-float biotech garner new investor attention. |
As I said last night, small biotech stocks often make a move higher weeks to months before major events. |
And MIRA might just have one coming soon! Like in 2024 for Ketamir-2. |
|
Make sure you do your research on MIRA and everything they are working on, but I think you'll find this useful from their website: |
What is Ketamir? |
A Novel Oral Ketamine Analog |
Ketamir-2 ("Ketamir") is under investigation to potentially orally deliver ultra-rapid antidepressant effects for patients who have not had a meaningful response to conventional treatments, providing new hope for individuals battling treatment-resistant depression (TRD) and major depressive disorder with suicidal ideation (MDSI). |
And with MIRA-55 right behind it, in the first half of 2025, it's starting to make sense to keep MIRA on your radar. |
Making the potential MIRA-55's initial IND submission in the first half of 2025 an interesting drug to watch. |
The chart, like a lot of stocks under $10, drifts and spikes, drifts and spikes. The key is to monitor for those spikes like GME did this past month, going from $10's to $60's. |
Below, you can see the GME "drift and spike pattern." |
|
As I said last night, MIRA is no stranger to the drift and spike pattern. Its last recent big move put up a performance that would make GME blush. |
|
Right now it's in drift mode back down to $.66 as of Friday's close. |
So the question becomes, will it spike again anytime soon? |
Always difficult to say but what we know about "bio runup" stocks is that they tend to start their rallies weeks to months in advance of the events. |
Biotech catalysts like INDs, PFUDA, phase I, II and III events can deliver some monster run-ups for stocks like MIRA. |
Will $.60's be the floor ahead of the next potential GME type spike? I can't answer that for you but it's safe to say I think it's worth watching here in the near-term. |
Spend time right now doing your own research on the stock, and of course, always approach your trading in a responsible manner. Trading is very risky, and nothing is ever guaranteed, so never trade with more than you can afford to lose. Always have a well-thought-out game plan that takes your personal risk tolerance into consideration. |
Bottom line: MIRA has a market-cap under $10M, a true nano-cap or the smallest of companies. Couple that with an extremely low float, and you can see how it recently went from $1.33-$6.40 in a week. Now, with it trading closer to $.60 and catalysts potentially in 2024 and early 2025, with a large addressable and fast growing market, I think there's a good argument it may spike again soon. |
Don't take your eyes off of MIRA today! 👀 |
To Your Success, |
|
P.S. Make sure you join me and over 1000 traders in the Market Master's trading room today for live trading signals and education. You can access it at no cost right now. |
|
*Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call "typical." |
Just a quick heads up about this ad you're reading—as we've said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received fifteen thousand dollars (cash) from Sica Media for advertising MIRA Pharmaceuticals, Inc for a one day marketing program on may 20, 2024. This amount was paid by someone else not connected to MIRA Pharmaceuticals, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case. |
Now, diving right into MIRA Pharmaceuticals, Inc might sound exciting. But remember, it's like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you're doing. That's why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r. |
Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We're simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We're obviously biased in our writing. We're not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as "forward-L00king statements" under the securities acts, so take those with a grain of salt. As with all forecasts, they're not set in stone, often wrong, and we certainly can't know where the Company's earnings, business, or share price will be tomorrow or a year from now. |
Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, |
Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep's with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization. |
So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture. |
Post a Comment
Post a Comment